DocGo Inc. Net Income
DocGo Inc. (DCGO) reported Net Income of -$15.82 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-17.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLoss · last filed 2026-08-17
- DocGo Inc. net income (loss) attributable to parent for the quarter ending 2026-06-30 was -$15.82M.
- DocGo Inc. net income (loss) attributable to parent for the quarter ending 2026-03-31 was -$14.76M.
- DocGo Inc. net income (loss) attributable to parent for the quarter ending 2025-12-31 was -$148.04M.
- DocGo Inc. net income (loss) attributable to parent for the quarter ending 2025-09-30 was -$27.77M, a 605.07% decline year-over-year.
- DocGo Inc. net income (loss) attributable to parent for fiscal 2022 was $34.58M, a 45.66% increase from fiscal 2021.
- DocGo Inc. net income (loss) attributable to parent for fiscal 2021 was $23.74M.
- DocGo Inc. net income (loss) attributable to parent for fiscal 2020 was -$14.80M.
| Period end | Net Income (Loss) Attributable to Parent 2 month | Net Income (Loss) Attributable to Parent 3 month | Net Income (Loss) Attributable to Parent 3 month as first filed | Net Income (Loss) Attributable to Parent 5 month | Net Income (Loss) Attributable to Parent 5 month as first filed | Net Income (Loss) Attributable to Parent 6 month | Net Income (Loss) Attributable to Parent 6 month as first filed | Net Income (Loss) Attributable to Parent 9 month | Net Income (Loss) Attributable to Parent 9 month as first filed | Net Income (Loss) Attributable to Parent 12 month | Net Income (Loss) Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$15.82M 10-Q · filed 2026-08-17 | -$30.58M 10-Q · filed 2026-08-17 | -$178.62M derived: sum of 3 quarters · filed 2026-08-17 | -$206.39M derived: sum of 4 quarters · filed 2026-08-17 | |||||||
| 2026-03-31 | -$14.76M 10-Q · filed 2026-08-17 | -$162.80M derived: sum of 2 quarters · filed 2026-08-17 | -$190.57M derived: sum of 3 quarters · filed 2026-08-17 | -$201.72M derived: sum of 4 quarters · filed 2026-08-17 | |||||||
| 2025-12-31 | -$148.04M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$175.81M derived: sum of 2 quarters · filed 2026-04-22 | -$186.96M derived: sum of 3 quarters · filed 2026-08-17 | -$196.37M DEF 14A · filed 2026-04-22 | -$182.40M 10-K · filed 2026-03-16 | ||||||
| 2025-09-30 | -$27.77M 10-Q · filed 2025-11-10 | -$38.92M derived: sum of 2 quarters · filed 2026-08-17 | -$48.33M 10-Q · filed 2025-11-10 | -$58.22M derived: sum of 4 quarters · filed 2026-08-17 | |||||||
| 2025-06-30 | -$11.16M 10-Q · filed 2026-08-17 | -$20.56M 10-Q · filed 2026-08-17 | -$30.45M derived: sum of 3 quarters · filed 2026-08-17 | -$24.96M derived: sum of 4 quarters · filed 2026-08-17 | |||||||
| 2025-03-31 | -$9.41M 10-Q · filed 2026-08-17 | -$19.30M derived: sum of 2 quarters · filed 2026-08-17 | -$13.80M derived: sum of 3 quarters · filed 2026-08-17 | -$7.27M derived: sum of 4 quarters · filed 2026-08-17 | |||||||
| 2024-12-31 | -$9.89M derived: DEF 14A 12 month − 10-Q 9 month · filed 2026-04-22 | -$4.40M derived: sum of 2 quarters · filed 2026-04-22 | $2.13M derived: sum of 3 quarters · filed 2026-04-22 | $13.36M DEF 14A · filed 2026-04-22 | $19.99M 10-K · filed 2026-03-16 | ||||||
| 2024-09-30 | $5.50M 10-Q · filed 2025-11-10 | $12.03M derived: sum of 2 quarters · filed 2025-11-10 | $23.25M 10-Q · filed 2025-11-10 | ||||||||
| 2024-06-30 | $6.53M 10-Q · filed 2025-11-10 | $17.76M 10-Q · filed 2025-08-07 | |||||||||
| 2024-03-31 | $11.23M 10-Q · filed 2025-11-10 | ||||||||||
| 2023-12-31 | $10.05M DEF 14A · filed 2026-04-22 | $6.86M 10-K · filed 2026-03-16 | |||||||||
| 2023-03-31 | -$3.47M 10-Q · filed 2023-05-09 | $7.52M derived: sum of 2 quarters · filed 2023-05-09 | $9.99M derived: sum of 3 quarters · filed 2023-05-09 | $21.75M derived: sum of 4 quarters · filed 2023-05-09 | |||||||
| 2022-12-31 | $10.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $13.46M derived: sum of 2 quarters · filed 2023-03-14 | $25.21M derived: sum of 3 quarters · filed 2023-03-14 | $34.58M 10-K · filed 2023-03-14 | |||||||
| 2022-09-30 | $2.47M 10-Q · filed 2022-11-08 | $14.22M derived: sum of 2 quarters · filed 2022-11-08 | $23.59M 10-Q · filed 2022-11-08 | $49.69M derived: sum of 4 quarters · filed 2023-05-09 | |||||||
| 2022-06-30 | $11.76M 10-Q · filed 2022-08-09 | $21.13M 10-Q · filed 2022-08-09 | $47.22M derived: sum of 3 quarters · filed 2023-05-09 | $48.03M derived: sum of 4 quarters · filed 2023-05-09 | |||||||
| 2022-03-31 | $10.63M 10-Q · filed 2023-05-09 | $9.37M 10-Q · filed 2022-05-10 | $35.47M derived: sum of 2 quarters · filed 2023-05-09 | $36.27M derived: sum of 3 quarters · filed 2023-05-09 | $36.37M derived: sum of 4 quarters · filed 2023-05-09 | ||||||
| 2021-12-31 | $24.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $25.64M derived: sum of 2 quarters · filed 2023-03-14 | $25.74M derived: sum of 3 quarters · filed 2023-03-14 | $23.74M 10-K · filed 2023-03-14 | $19.18M 10-K · filed 2022-03-15 | ||||||
| 2021-09-30 | $801.57K 10-Q · filed 2022-11-08 | $544.49K 10-Q · filed 2021-11-15 | $903.57K derived: sum of 2 quarters · filed 2022-11-08 | -$1.10M 10-Q · filed 2022-11-08 | -$508.21K 10-Q · filed 2021-11-15 | ||||||
| 2021-06-30 | $102.01K 10-Q · filed 2022-08-09 | -$3.04M 10-Q · filed 2021-08-11 | -$1.90M 10-Q · filed 2022-08-09 | -$1.05M 10-Q · filed 2021-08-11 | |||||||
| 2021-03-31 | -$2.00M 10-Q · filed 2022-05-10 | $1.99M 10-Q · filed 2021-06-03 | |||||||||
| 2020-12-31 | -$4.22M 10-K/A · filed 2021-11-24 | -$148.75K 10-K · filed 2021-03-30 | -$14.80M 10-K · filed 2022-03-15 | ||||||||
| 2020-09-30 | -$2.06K 10-Q/A · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |